Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials.

Manuel BenavidesEduardo Díaz-RubioAlfredo CarratoAlbert AbadCarmen Guillén-PoncePilar Garcia-AlfonsoSilvia GilMaría Teresa CanoMaría José SafontCristina GravalosJosé Luis ManzanoAntonio SánchezJulia AlcaideRafael LópezBartomeu MassutíJavier SastreEva MartínezPilar EscuderoMiguel MéndezEnrique Aranda

Published in: ESMO open (2019)

NCT01161316 and NCT00885885.

Keyphrases

wild type
phase ii
metastatic colorectal cancer
open label
clinical trial
placebo controlled
double blind
small cell lung cancer
epidermal growth factor receptor
phase iii
tyrosine kinase
study protocol
cross sectional